Two Sigma Investments’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.6K | Sell |
14,404
-9,186
| -39% | -$27.8K | ﹤0.01% | 3029 |
|
|
2025
Q1 | $100K | Buy |
23,590
+9,957
| +73% | +$42.4K | ﹤0.01% | 2903 |
|
|
2024
Q4 | $72K | Sell |
13,633
-171,590
| -93% | -$906K | ﹤0.01% | 2943 |
|
|
2024
Q3 | $339K | Buy |
185,223
+29,450
| +19% | +$53.9K | ﹤0.01% | 2565 |
|
|
2024
Q2 | $324K | Buy |
155,773
+136,025
| +689% | +$283K | ﹤0.01% | 2485 |
|
|
2024
Q1 | $79.2K | Sell |
19,748
-5,397
| -21% | -$21.6K | ﹤0.01% | 2776 |
|
|
2023
Q4 | $47.1K | Sell |
25,145
-2,200
| -8% | -$4.13K | ﹤0.01% | 2911 |
|
|
2023
Q3 | $45.7K | Sell |
27,345
-7,400
| -21% | -$12.4K | ﹤0.01% | 2749 |
|
|
2023
Q2 | $83K | Sell |
34,745
-1,000
| -3% | -$2.39K | ﹤0.01% | 2695 |
|
|
2023
Q1 | $112K | Sell |
35,745
-10,402
| -23% | -$32.6K | ﹤0.01% | 2583 |
|
|
2022
Q4 | $124K | Sell |
46,147
-4,901
| -10% | -$13.1K | ﹤0.01% | 2421 |
|
|
2022
Q3 | $151K | Sell |
51,048
-2,500
| -5% | -$7.4K | ﹤0.01% | 2116 |
|
|
2022
Q2 | $157K | Sell |
53,548
-35,231
| -40% | -$103K | ﹤0.01% | 2144 |
|
|
2022
Q1 | $454K | Sell |
88,779
-101,499
| -53% | -$519K | ﹤0.01% | 2030 |
|
|
2021
Q4 | $1.28M | Buy |
190,278
+59,343
| +45% | +$400K | ﹤0.01% | 1539 |
|
|
2021
Q3 | $906K | Buy |
130,935
+75,530
| +136% | +$523K | ﹤0.01% | 1737 |
|
|
2021
Q2 | $540K | Buy |
+55,405
| New | +$540K | ﹤0.01% | 1932 |
|
|
2021
Q1 | – | Sell |
-28,599
| Closed | -$692K | – | 2702 |
|
|
2020
Q4 | $692K | Buy |
28,599
+18,480
| +183% | +$447K | ﹤0.01% | 1483 |
|
|
2020
Q3 | $170K | Buy |
+10,119
| New | +$170K | ﹤0.01% | 1705 |
|